NEXUS SURGICAL AND MEDICARE LI (NEXUSSURGL.BO)
INR 22.99
(1.37%)
INR 22.99
(1.37%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 12.39 Million INR | 120.41% |
| 2022 | 5.62 Million INR | -69.11% |
| 2021 | 18.21 Million INR | 74.65% |
| 2020 | 10.42 Million INR | 119.84% |
| 2019 | 4.74 Million INR | 2.14% |
| 2018 | 4.64 Million INR | 4.59% |
| 2017 | 4.44 Million INR | -5.01% |
| 2016 | 4.67 Million INR | 243.92% |
| 2015 | 1.35 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q3 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 9.26 Million INR | 0.0% |
| 2023 Q4 | 12.39 Million INR | 0.0% |
| 2023 FY | 12.39 Million INR | 120.41% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 6.88 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q4 | 5.62 Million INR | 0.0% |
| 2022 FY | 5.62 Million INR | -69.11% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 18.21 Million INR | 74.65% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 18.21 Million INR | 0.0% |
| 2021 Q2 | 2.1 Million INR | 0.0% |
| 2020 FY | 10.42 Million INR | 119.84% |
| 2020 Q4 | 10.42 Million INR | 0.0% |
| 2019 FY | 4.74 Million INR | 2.14% |
| 2018 FY | 4.64 Million INR | 4.59% |
| 2017 FY | 4.44 Million INR | -5.01% |
| 2016 FY | 4.67 Million INR | 243.92% |
| 2015 FY | 1.35 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Chandra Bhagat Pharma Limited | 727.95 Million INR | 98.297% |
| Checkpoint Trends Limited | 4 Million INR | -209.436% |
| Everest Organics Limited | 1.8 Billion INR | 99.314% |
| GUJARAT INJECT (KERALA) LTD. | 1.47 Million INR | -742.961% |
| NATURO INDIABULL LIMITED | 537.34 Million INR | 97.692% |
| Rajnish Wellness Limited | 222.75 Million INR | 94.433% |
| Rama Vision Limited | 291.78 Million INR | 95.75% |
| Vivo Bio Tech Limited | 827.33 Million INR | 98.501% |